BUFDX
Price
$31.53
Change
-$0.10 (-0.32%)
Updated
May 23 closing price
Net Assets
166.69M
VFIAX
Price
$536.38
Change
-$3.60 (-0.67%)
Updated
May 23 closing price
Net Assets
1.33T
Interact to see
Advertisement

BUFDX vs VFIAX

Header iconBUFDX vs VFIAX Comparison
Open Charts BUFDX vs VFIAXBanner chart's image
Buffalo Growth & Income
Price$31.53
Change-$0.10 (-0.32%)
VolumeN/A
Net Assets166.69M
Vanguard 500 Index Admiral
Price$536.38
Change-$3.60 (-0.67%)
VolumeN/A
Net Assets1.33T
BUFDX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BUFDX vs. VFIAX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUFDX is a Buy and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.34T vs. BUFDX (167M). BUFDX pays higher dividends than VFIAX: BUFDX (1.69) vs VFIAX (1.36). BUFDX was incepted earlier than VFIAX: BUFDX (12 years) vs VFIAX (25 years). BUFDX (0.94) is less costly to investors than VFIAX (0.04). BUFDX is a more actively managed with annual turnover of: 4.00 vs. VFIAX (2.00). BUFDX has a lower initial minimum investment than VFIAX: BUFDX (2500) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 10.16 vs. BUFDX (7.26). VFIAX return over 5 years is better than : 97.64 vs. BUFDX (91.46).
BUFDXVFIAXBUFDX / VFIAX
Total Expense Ratio0.940.042,350%
Annual Report Gross Expense Ratio0.940.042,350%
Fund Existence12 years25 years-
Gain YTD-1.824-0.456400%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets167M1.34T0%
Annual Yield % from dividends1.691.36125%
Returns for 1 year7.2610.1671%
Returns for 3 years37.4447.1279%
Returns for 5 years91.4697.6494%
Returns for 10 years141.95175.0981%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALZN3.560.04
+1.14%
Alzamend Neuro Inc.
SWKS71.35N/A
N/A
Skyworks Solutions
CMPR42.82N/A
N/A
Cimpress plc
KALV11.87N/A
N/A
KalVista Pharmaceuticals
TRX0.31N/A
-0.38%
TRX Gold Corp